The role of staphylococcal polysaccharide microcapsule expression in septicemia and septic arthritis

Infection and Immunity

Volumn 65, Issue 10, 1997, Pages 4216-4221

  Nilsson, Ing Marie ^a,d   Lee, Jean C ^b   Bremell, Tomas ^a   Rydén, Cecilia ^c   Tarkowski, Andrzej ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d Department of Rheumatology ^*  (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL ARTHRITIS; BACTERIAL MEMBRANE; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; BACTERIUM MUTANT; COLONY FORMING UNIT; CONTROLLED STUDY; INOCULATION; MALE; MOUSE; NONHUMAN; PATHOGENICITY; PHAGOCYTOSIS; PRIORITY JOURNAL; SEPTICEMIA; STAPHYLOCOCCUS AUREUS;

EID: 0030765751     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.10.4216-4221.1997     Document Type: Article

References (31)

1. Abdelnour, A., S. Arvidson, T. Bremell, C. Rydén, and A. Tarkowski. 1993. The accessory gene regulator (agr) controls Staphylococcus aureus virulence in a murine arthritis model. Infect. Immun. 61:3879-3885.
2. Abdelnour, A., T. Bremell, R. Holmdahl, and A. Trakowski. 1994. Clonal expression of T lymphocytes causes arthritis and mortality in mice infected with toxic shock syndrome toxin-1-producing staphylococci. Eur. J. Immunol. 24:1161-1166.
3. Albus, A., R. D. Arbeit, and J. C. Lee. 1991. Virulence of Staphylococcus aureus mutants altered in type 5 capsule production. Infect. Immun. 59: 1008-1014.
4. Baddour, L. M., C. Lowrance, A. Albus, J. H. Lowrance, S. K. Anderson, and J. C. Lee. 1992. Staphylococcus aureus microcapsule attenuates bacterial virulence in a rat model of experimental endocarditis. J. Infect. Dis. 165:749-753.
5. Bremell, T., A. Abdelnour, and A. Tarkowski. 1992. Histopathological and serological progression of experimental Staphylococcus aureus arthritis. Infect. Immun. 60:2976-2985.
6. Bremell, T., S. Lange, A. Yacoub, C. Rydén, and A. Tarkowski. 1991. Experimental Staphylococcus aureus arthritis in mice. Infect. Immun. 59:2615-2623.
7. Fattom, A., R. Schneerson, S. C. Szu, W. F. Vann, J. Shiloach, W. W. Karakawa, and J. B. Robbing. 1990. Synthesis and immunologic properties in mice of vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides conjugated to Pseudomonas aeruginosa exotoxin A. Infect. Immun. 58:2367-2374.
8. Fournier, J. 1990. Capsular polysaccharides of Staphylococcus aureus, p. 533-544. In T. Wadström, E. Ingvar, I. Holder, and A. Ljung (ed.), Pathogenesis of wound and biomaterial-associated infections. Springer-Verlag, London, England.
9. Goldenberg, D. L., and J. I. Reed. 1985. Bacterial arthritis. N. Engl. J. Med. 312:764-771.
10. Helle, M., L. Boeije, and L. Aarden. 1988. Functional discrimination between interleukin 6 and interleukin 1. Eur. J. Immunol. 18:1525-1540.
11. Karakawa, W. W., J. M. Fournier, W. F. Vann, R. Arbeit, R. S. Schneerson, and J. B. Robbins. 1985. Method for serological typing of the capsular polysaccharides of Staphylococcus aureus. J. Clin. Microbiol. 22:445-447.
12. Karakawa, W. W., and W. F. Vann. 1982. Capsular polysaccharides of Staphylococcus aureus, p. 285-293. In J. B. Robbins, J. C. Hill, and J. C. Sadoff (ed.), Bacterial vaccines, vol. 4. Thieme Stratton, New York, N.Y.
13. Koening, M. G. 1962. Factors relating to the virulence of staphylococci. I. Comparative studies on two colonial variants. Yale J. Biol. Med. 34:943-949.
14. Lee, J. C., M. J. Betley, C. A. Hopkins, N. E. Perez, and G. B. Pier. 1987. Virulence studies, in mice, of transposon-induced mutants of Staphylococcus aureus differing in capsule size. J. Infect. Dis. 156:741-750.
15. Lee, J. C., C. A. Hopkins, and G. B. Pier. 1985. The role of Staphylococcus aureus capsule in abscess formation. Zentralbl. Bakteriol. Suppl. 14:219-224.
16. Lee, J. C., N. E. Perez, C. A. Hopkins, and G. B. Pier. 1988. Purified capsular polysaccharide-induced immunity to Staphylococcus aureus infection. J. Infect. Dis. 157:723-730.
17. Lissner, C. R., R. Swansson, and A. D. O'Brien. 1983. Genetic control of the innate resistance of mice to Salmonella typhimurium: expression of the Ity gene in peritoneal and splenic macrophages isolated in vitro. J. Immunol. 131:3006-3013.
18. Markwell, M. 1982. A new solid-state reagent to iodinate proteins. I. Conditions for the efficient labeling of antiserum. Anal. Biochem. 125:427-432.
19. Marrack, P., M. Blackman, E. Kushnir, and J. Kappler. 1990. The toxicity of staphylococcal enterotoxin B in mice is mediated by T cells. J. Exp. Med. 171:455-464.
20. Miethke, T., C. Wahl, K. Heeg, B. Echtenacher, P. H. Krammer, and H. Wagner. 1992. T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor. J. Exp. Med. 175:91-98.
21. Nemeth, J., and J. C. Lee. 1995. Antibodies to capsular polysaccharides are not protective against experimental Staphylococcus aureus endocarditis. Infect. Immun. 63:375-380.
22. Paliard, X., S. G. West, J. A. Lafferty, J. R. Clements, J. W. Kappler, P. Marrack, and B. L. Kotzin. 1991. Evidence for effects of superantigen in rheumatoid arthritis. Science 253:325-329.
23. Peterson, P. K., B. J. Wilkinson, Y. Kim, D. Schmeling, and P. G. Quie. 1978. Influence of encapsulation on staphylococcal opsonization and phagocytosis by human polymorphonuclear leukocytes. Infect. Immun. 19:943-949.
24. Rydén, C., A. Yacoub, I. Maxe, D. Heinegård, Å. Oldberg, A. Franzén, Å. Ljungh, and K. Rubin. 1989. Specific binding of bone sialoprotein to Staphylococcus aureus from patients with osteomyelitis. Eur. J. Biochem. 184:331-336.
25. Soell, M., M. Diab, G. Haan-Archipoff, A. Beretz, C. Herbelin, B. Poutrel, and J.-P. Klein. 1995. Capsular polysaccharide types 5 and 8 of Staphylococcus aureus bind to human epithelial (KB) cells, endothelial cells, and monocytes and induce release of cytokines. Infect. Immun. 63:1380-1386.
26. Verbrugh, H. A., P. K. Peterson, B. T. Nguyen, S. P. Sisson, and Y. Kim. 1982. Opsonization of encapsulated Staphylococcus aureus: the role of specific antibody and complement. J. Immunol. 129:1681-1687.
27. Wiley, B., and N. Maverakis. 1974. Capsule production and virulence among strains of Staphylococcus aureus. Ann. N. Y. Acad. Sci. 236:221-232.
28. Wilkinson, B. 1983. Staphylococcal capsules and slime, p. 481-523. In C. E. and C. Adlam (ed.), Staphylococci and staphylococcal infections. Academic Press, London, England.
29. Wilkinson, B. J., P. K. Peterson, and P. G. Quie. 1979. Cryptic peptidoglycan and the antiphagocytic effect of the Staphylococcus aureus capsule: model for the antiphagocytic effect of bacterial cell surface polymers. Infect. Immun. 23:502-508.
30. Xu, S., R. D. Arbeit, and J. C. Lee. 1992. Phagocytic killing of encapsulated and microencapsulated Staphylococcus aureus by human polymorphonuclear leukocytes. Infect. Immun. 60:1358-1362.
31. Zhao, Y.-X., A. Abdelnour, R. Holmdahl, and A. Tarkowski. 1995. Mice with the Xid B cell defect are less susceptible to developing Staphylococcus aureum-induced arthritis. J. Immunol. 155:2067-2076.